Showing 8451-8460 of 9758 results for "".
- Dermatologist Warns of "Lime Disease"—Phytophotodermatosis—In Conjunction with National Tequila Dayhttps://practicaldermatology.com/news/dermatologist-warns-of-lime-diseasephytophotodermatosisin-conjunction-with-national-tequila-day/2458907/Margaritas may be the choice cocktail on July 24 to celebrate National Tequila Day, but Dr. Howard Steinman, a dermatologist with DermOne Dermatology Centers, has a sour warning: Sipping citrus fruit
- Investigational Foam May Offer Itch Relief for Psoriasis Patientshttps://practicaldermatology.com/news/investigational-foam-may-offer-itch-relief-for-psoriasis-patients/2458931/An investigational aerosol foam may provide rapid itch relief as well as improvements in itch-related sleep loss for patients with psoriasis, according to new data presented at the recent World Congress of Dermatology. According to the Phase 3 clinical trial, 426 psoriasis patients were split int
- NIH Funding Often Does Not Match Disease Burden for Dermatologic Conditionshttps://practicaldermatology.com/news/nih-funding-often-does-not-match-disease-burden-for-dermatologic-conditions/2458930/A new analysis of funding prioritization by the National Institutes of Health for skin disease offers a glimpse of cutaneous skin disease on a national level, with some disease states being possibly underfunded. Examining the relationship between dermatologic research funding and skin disease bur
- KYTHERA Biopharmaceuticals Announces FDA Approval of KYBELLA(TM) (also known as ATX-101) -- First and Only Submental Contouring Injectable Drughttps://practicaldermatology.com/news/kythera-biopharmaceuticals-announces-fda-approval-of-kybellatm-also-known-as-atx-101-first-and-only-submental-contouring-injectable-drug/2458953/KYTHERA Biopharmaceuticals, Inc. (Nasdaq:
- Senate Passes Bill to Repeal SGRhttps://practicaldermatology.com/news/senate-passes-bill-to-repeal-sgr/2458967/This week saw the end of the sustainable growth rate (SGR), with the US Senate passing the Medicare Access and CHIP Reauthorization Act (H.R.2) in a 92-8 vote and President Obama signing it into law. The bill, which the Hous
- Dr. Reddy's and its Subsidiary Promius Pharma File Three NDAshttps://practicaldermatology.com/news/dr-reddys-and-its-subsidiary-promius-pharma-announce-filing-of-three-ndas/2458971/Dr. Reddy's Laboratories and its subsidiary, Promius Pharma, LLC filed three 505(b)(2) New Drug Applications (NDAs) with the FDA. The three NDAs - DFD-01, DFD-09, and DFN-11, are in support of Dr. Reddy’s Proprietary Products group, focused on developing and commercializing therapies in
- Nextech Systems and Iagnosis Showcase New Partnershiphttps://practicaldermatology.com/news/nextech-systems-and-iagnosis-showcase-new-partnership/2458982/Nextech, a leading provider of specialty-focused healthcare technology solutions for physician practices, announced an exclusive partnership with Iagnosis, a leading telemedicine provider of online dermatology solutions. Iagnosis provides a teledermatolog
- Envy Medical Unveils SilkPeel3https://practicaldermatology.com/news/envy-medical-unveils-silkpeel3/2458990/Envy Medical, Inc. will launch its SilkPeel3, the next generation of its Advanced Dermalinfusion Technology, at the Annual Meeting of the American Academy of Dermatology on March 20-24 in San Francisco at Booth 312. Unveiled originally in 2005, SilkPeel is celebrating its 10th
- Nanotechnology Study Offers New Direction for Wound Healing Therapyhttps://practicaldermatology.com/news/nanotechnology-study-offers-new-direction-for-wound-healing-therapy/2458991/A novel nanoparticle technology appears to promote wound healing and has led researchers to a new therapeutic target for wound healing, a new study says. Writing in Journal of Investigat
- Cosmederm Bioscience Introduces Steve Massah as New Chief Operating Officerhttps://practicaldermatology.com/news/cosmederm-bioscience-introduces-steve-massah-as-new-chief-operating-officer/2459004/Cosmederm Bioscience has hired Steve Massah as its new Chief Operating Officer. As COO, Massah will provide strategic and tactical leadership, and management of manufacturing, product development, quality and product shipment and logistics. His work will ensure compliance with all government regu